Cuorips surged following reports of a press conference involving surgery using “ReHeart,” an iPS cell-derived cardiac muscle sheet. Space-development-related stocks were also bought on related news, while AI- and security-related news supported the market. Reports of closing prices today, partnerships and facility completions followed one after another.
Cuorips surged after reports that a press conference had been held with a patient who underwent the world's first surgery using “ReHeart,” an iPS cell-derived cardiac muscle sheet, and that the patient was recovering well postoperatively and was scheduled to be discharged on the 22nd. The shares rose into the ¥7,000 range, apparently attracting buying orders.
Dynamap announced that it would participate as a sponsor in a mobility development competition for North American university students. The company presented plans to provide high-precision 3D map data, raising expectations for the development of mobility solutions.
Sinspective and other space-development-related stocks were bought, and related stocks were active in overnight trading following reports that SpaceX's 2026 third-quarter results had exceeded market expectations for both revenue and profit.
GMO GlobalSign Holdings announced the addition of the “AI Flow option,” which links with AI agents, to its electronic contract service. Its support for MCP, a common standard connecting AI with external services, attracted attention.